{"cik":"0001980845","ticker":"ENGN","name":"enGene Therapeutics Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"Z4","fiscal_year_end":"1031","first_filing_date":"2026-05-13","last_filing_date":"2026-08-11","url":"/sec/cik-0001980845","insider_summary":{"total_transactions":9,"unique_insiders":8,"latest_transaction":"2026-06-16"},"recent_filings":[{"accession_number":"0001193125-26-344559","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — enGene Therapeutics Inc. — 2026-08-11","url_slug":"/sec/cik-0001980845/8-k/0001193125-26-344559","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-344559-index.html"},{"accession_number":"0000929638-26-002667","form_type":"3","form_type_family":"insider","doc_date":"2026-07-22","title":"3 — enGene Therapeutics Inc. — 2026-07-22","url_slug":"/sec/cik-0001980845/3/0000929638-26-002667","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0000929638-26-002667-index.html"},{"accession_number":"0000929638-26-002666","form_type":"3","form_type_family":"insider","doc_date":"2026-07-22","title":"3 — enGene Therapeutics Inc. — 2026-07-22","url_slug":"/sec/cik-0001980845/3/0000929638-26-002666","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0000929638-26-002666-index.html"},{"accession_number":"0001193125-26-307795","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-17","title":"8-K — enGene Therapeutics Inc. — 2026-07-17","url_slug":"/sec/cik-0001980845/8-k/0001193125-26-307795","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-307795-index.html"},{"accession_number":"0001193125-26-275815","form_type":"8-K/A","form_type_family":"current","doc_date":"2026-06-18","title":"8-K/A — enGene Therapeutics Inc. — 2026-06-18","url_slug":"/sec/cik-0001980845/8-k-a/0001193125-26-275815","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-275815-index.html"},{"accession_number":"0001193125-26-270384","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-15","title":"8-K — enGene Therapeutics Inc. — 2026-06-15","url_slug":"/sec/cik-0001980845/8-k/0001193125-26-270384","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-270384-index.html"},{"accession_number":"0001193125-26-270386","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-06-15","title":"10-Q — enGene Therapeutics Inc. — 2026-06-15","url_slug":"/sec/cik-0001980845/10-q/0001193125-26-270386","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-270386-index.html"},{"accession_number":"0001193125-26-265830","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-10","title":"8-K — enGene Therapeutics Inc. — 2026-06-10","url_slug":"/sec/cik-0001980845/8-k/0001193125-26-265830","edgar_url":"https://www.sec.gov/Archives/edgar/data/1980845/0001193125-26-265830-index.html"}],"related_endpoints":{"profile":"/sec/ENGN/profile","timeline":"/sec/ENGN/timeline","peers":"/sec/ENGN/peers","insider_pulse":"/sec/ENGN/insider-pulse","insider_summary":"/sec/ENGN/insider-summary","insider_transactions":"/sec/ENGN/insider-transactions","form144":"/sec/ENGN/form144","holdings_as_filer":"/sec/ENGN/holdings","financial_facts":"/sec/ENGN/financial-facts","derivatives":"/sec/ENGN/derivatives","officers":"/sec/ENGN/officers","insider_network":"/sec/ENGN/insider-network","risk_flags":"/sec/ENGN/risk-flags","filings":"/sec/ENGN/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ENGN"}}